Delisting risk
SILO · NASDAQ · Biotechnology

Silo Pharma (SILO)

Licenses preclinical CNS therapies while building QwikAgents and a cryptocurrency treasury.

$2.49
Pre-market−0.07 (−2.92%)
At close$2.57(+5.12%)

Breakdown13F · 13D/G · Form 4

Institutions14 holders · as of Mar 31, 20266.24%70.4K shares
Insiders1 holder · as of Dec 16, 20251.28%14.5K shares
Otherremainder92.48%1.04M shares

1.13M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (1.59M in the company's Sep 3, 2026 report, 1.13M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
AdvisorShares TrustInstitution
6.70%75,58213Gfiled Jul 8, 2026
Advisorshares Investments LLCInstitution
3.92%663,96513Fas of Mar 31, 2026
Eric WeisblumInsiderdirector, officer: Chief Executive Officer
1.28%14,462Form 4filed Dec 16, 2025
Geode Capital Management, LLCInstitution
1.06%180,03113Fas of Mar 31, 2026
Susquehanna International Group, LLPInstitution
0.37%62,79513Fas of Mar 31, 2026
Jane Street Group, LLCInstitution
0.26%44,76313Fas of Mar 31, 2026
Citadel Advisors LLCInstitution
0.13%21,44813Fas of Mar 31, 2026
XTX Topco LtdInstitution
0.10%17,08313Fas of Mar 31, 2026
Two Sigma Securities, LLCInstitution
0.09%14,50313Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.08%13,10013Fas of Mar 31, 2026
LPL Financial LLCInstitution
0.07%12,53413Fas of Mar 31, 2026
State Street CorpInstitution
0.07%12,50013Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
0.07%11,22113Fas of Mar 31, 2026
Tower Research Capital LLC (TRC)Institution
0.01%1,67713Fas of Mar 31, 2026
Ifp Advisors, IncInstitution
0.00%17513Fas of Mar 31, 2026
Wells Fargo & Company/MNInstitution
0.00%1013Fas of Mar 31, 2026
High River Limited PartnershipInstitution
3.40% of class, as filed13Gfiled Jul 30, 2018
Joseph RedaInsider
9.99% of class, as filed13Gfiled Nov 16, 2022
Mitchell P. KopinInsider
9.99% of class, as filed13Gfiled Feb 13, 2026
WilfongInsider
6.50% of class, as filed13Gfiled May 21, 2020
Daniel E. Ryweck1Insiderofficer: Chief Financial Officer
0.03%333Form 4filed May 26, 2023
  1. Last filed May 26, 2023; leaving the company requires no filing. Not in the bar.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

14 holders · 1.06M shares · 6 new positions · 10 increased · 2 reduced · 7 closed

HolderShares% outstandingChg q/qFiled
Advisorshares Investments LLC664.0K58.83%+64.5KApr 28, 2026
Geode Capital Management, LLC180.0K15.95%+87.1KMay 15, 2026
Susquehanna International Group, LLP62.8K5.56%+33.2KMay 15, 2026
Jane Street Group, LLC44.8K3.97%+10.4KMay 12, 2026
Citadel Advisors LLC21.4K1.90%+21.4KnewMay 15, 2026
XTX Topco Ltd17.1K1.51%−39.8KMay 15, 2026
Two Sigma Securities, LLC14.5K1.29%+14.5KMay 15, 2026
Vanguard Fiduciary Trust Co13.1K1.16%+13.1KnewMay 8, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Mitchell P. Kopin9.99%13GFeb 13, 2026
AdvisorShares Trust6.69%75.6K13GJul 8, 2026

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Dec 15, 2025
Eric Weisblumdirector, officer: Chief Executive Officer
Purchase · 2 lots5,000$0.4150216,932
Nov 20, 2025
Eric Weisblumdirector, officer: Chief Executive Officer
Purchase1,000$0.3700210,932
Nov 21, 2025
Eric Weisblumdirector, officer: Chief Executive Officer
Purchase1,000$0.3650211,932
Nov 18, 2025
Eric Weisblumdirector, officer: Chief Executive Officer
Purchase7,500$0.4033205,432
Nov 19, 2025
Eric Weisblumdirector, officer: Chief Executive Officer
Purchase4,500$0.4050209,932

CongressHouse and Senate disclosures

Not reported.